3.0
Nov 15, 2014
Current employee, more than 8 years
Recommend
CEO approval
Business Outlook
Pros
Collaborative environment. People-focused. Bright and dedicated colleagues.
Cons
conservative, risk averse. Company is trying to diversify the risks of developing pharmaceutical products that require high drug price to recoup the investment. After all, all major countries will eventually follow UK model.